Search - tctmd.com

Displaying 181 - 200 of 280

Sort: Relevancy | Date

Presentation TCT 2013

TCT-13. Final Five Year Results From The All-comer COMPARE Trial: A Prospective, Randomized Trial of Everolimus-Eluting vs. Paclitaxel-Eluting Stents

Presenter: Peter Smits

October 29, 2013

News Daily News

Paclitaxel-Eluting Balloon-Plus-BMS Strategy Fares Poorly vs. EES in De Novo Stenosis

October 15, 2013

News Daily News

EXECUTIVE: Xience Performs Well in Patients with Less Complex Multivessel Disease

October 15, 2013

News Daily News

SPIRIT Meta-analysis Confirms Overall Superiority of Xience over Taxus

September 20, 2013

Presentation

Meta-analysis of Everolimus-Eluting vs. Paclitaxel-Eluting Stents in CAD

Presenter: George D. Dangas

September 16, 2013

News Daily News

SES Show Advantage Over ZES, PES for Diabetic Patients

Yael L. Maxwell

June 20, 2013

News Conference News EuroPCR 2013

EuroPCR 2013: From Cutting-Edge Devices to the Clinical Challenges

Caitlin E. Cox

May 29, 2013

News Daily News

TWENTE: Still Few Differences between ZES and EES at 2 Years

L.A. McKeown

May 03, 2013

News Daily News

TWENTE: Sigue habiendo Pequeñas Diferencias entre los SLZ y los SLE a los 2 Años

L.A. McKeown

May 03, 2013

Presentation ACC 2013

Three-Year Results of the PLATINUM Randomized Trial Comparing Platinum Chromium PROMUS Element and Cobalt Chromium PROMUS/XIENCE V Everolimus-Eluting Stents

Presenter: Ian T. Meredith

March 09, 2013

News Conference News ACC 2013

Is Nobori NEXT? Biodegradable-Polymer DES Noninferior to EES

Jason Kahn

March 09, 2013

News Conference News ACC 2013

Pair of Studies Show Positive Stent Results at ACC

Yael L. Maxwell

March 08, 2013

Presentation

Randomized Comparison of Sirolimus-eluting (SES) and Everolimus-eluting (EES) Coronary Stents in the Treatment of Total Coronary Occlusions

Presenter: 13956|Raul Moreno

February 24, 2013

Presentation TCT 2013

Two-Year Outcomes Following Implantation of 32mm and 38mm Platinum Chromium Everolimus Eluting Element Stents in Long Coronary Lesions

Presenter: Paul Teirstein, Gregg Stone, Ian Meredith, Robert Feldman, Joseph Dens, Abram Rabinowitz, Christophe Dubois, Dominic Allocco, Keith Dawkins

January 31, 2013

Presentation TCT 2013

Randomized comparison of Biolimus-eluting (Nobori) and Everolimus-eluting (Xience/Promus) stents in patients with multivessel coronary artery disease: 12-month follow-up data...

Presenter: Peter Smits, A. J. van Boven, Mariano Valdes, Antonio Serra, Jean-Jacques Goy, V. Voudris, Ramiro Trillo, J. M. Vazquez, Peter den Heijer, Ton Slagboom, A.G. Vuillomenet

January 31, 2013

$Partial strut fracture in everolimus-eluting stents: An intravascular ultrasound study$

Presentation TCT 2013

Partial strut fracture in everolimus-eluting stents: An intravascular ultrasound study

Presenter: Shinji Inaba, Gary Mintz, Kyeong Yun, Tadayuki Yakushiji, Takehisa Shimizu, Giora Weisz, Martin Leon, Jeffrey Moses, Gregg Stone, Akiko Maehara

January 31, 2013

Presentation TCT 2013

Everolimus Eluting Stents Versus First Generation Drug Eluting Stents (Sirolimus or Paclitaxel) for Treatment of Drug-Eluting Stent In-Stent Restenosis

Presenter: Sachin Goel, Wael El-Mallah, Mobolaji Ige, Supriya Gupta, E Murat Tuzcu, Stephen Ellis, Samir Kapadia

January 31, 2013

Presentation TCT 2013

Cost Effectiveness Of Everolimus-Eluting Stents Compared To First Generation Drug-Eluting Stents In Contemporary Clinical Practice

Presenter: Robert Applegate, Matthew Sacrinty, Sanjay Gandhi, Michael Kutcher, Renato Santos, Timothy Smith, William Little

January 31, 2013

Presentation TCT 2013

Cost Effectiveness Of Everolimus-Eluting Stents Compared To Propensity Score Matched Bare Metal Stents In Contemporary Clinical Practice

Presenter: Robert Applegate, Matthew Sacrinty, Sanjay Gandhi, Michael Kutcher, Renato Santos, Timothy Smith, William Little

January 31, 2013

Presentation TCT 2013

Comparison of Zotarolimus-Eluting stents versus Everolimus –Eluting stents versus Sirolimus-Eluting and in Patients with Long Coronary Artery Lesions Assessed by Volumetric...

Presenter: Young-Rak Cho, Jung-Min Ahn, Soo-Jin Kang, Young-Hak Kim, Won-Jang Kim, Jong-Young Lee, Woo Seok Lee, Gyung-Min Park, Seung-Jung Park

January 31, 2013

Advertisement

TCT-13. Final Five Year Results From The All-comer COMPARE Trial: A Prospective, Randomized Trial of Everolimus-Eluting vs. Paclitaxel-Eluting Stents

Paclitaxel-Eluting Balloon-Plus-BMS Strategy Fares Poorly vs. EES in De Novo Stenosis

EXECUTIVE: Xience Performs Well in Patients with Less Complex Multivessel Disease

SPIRIT Meta-analysis Confirms Overall Superiority of Xience over Taxus

Meta-analysis of Everolimus-Eluting vs. Paclitaxel-Eluting Stents in CAD

SES Show Advantage Over ZES, PES for Diabetic Patients

EuroPCR 2013: From Cutting-Edge Devices to the Clinical Challenges

TWENTE: Still Few Differences between ZES and EES at 2 Years

TWENTE: Sigue habiendo Pequeñas Diferencias entre los SLZ y los SLE a los 2 Años

Three-Year Results of the PLATINUM Randomized Trial Comparing Platinum Chromium PROMUS Element and Cobalt Chromium PROMUS/XIENCE V Everolimus-Eluting Stents

Is Nobori NEXT? Biodegradable-Polymer DES Noninferior to EES

Pair of Studies Show Positive Stent Results at ACC

Randomized Comparison of Sirolimus-eluting (SES) and Everolimus-eluting (EES) Coronary Stents in the Treatment of Total Coronary Occlusions

Two-Year Outcomes Following Implantation of 32mm and 38mm Platinum Chromium Everolimus Eluting Element Stents in Long Coronary Lesions

Randomized comparison of Biolimus-eluting (Nobori) and Everolimus-eluting (Xience/Promus) stents in patients with multivessel coronary artery disease: 12-month follow-up data...

Partial strut fracture in everolimus-eluting stents: An intravascular ultrasound study

Everolimus Eluting Stents Versus First Generation Drug Eluting Stents (Sirolimus or Paclitaxel) for Treatment of Drug-Eluting Stent In-Stent Restenosis

Cost Effectiveness Of Everolimus-Eluting Stents Compared To First Generation Drug-Eluting Stents In Contemporary Clinical Practice

Cost Effectiveness Of Everolimus-Eluting Stents Compared To Propensity Score Matched Bare Metal Stents In Contemporary Clinical Practice

Comparison of Zotarolimus-Eluting stents versus Everolimus –Eluting stents versus Sirolimus-Eluting and in Patients with Long Coronary Artery Lesions Assessed by Volumetric...

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content